10.46
price up icon0.77%   0.08
after-market アフターアワーズ: 10.50 0.04 +0.38%
loading
前日終値:
$10.38
開ける:
$10.45
24時間の取引高:
500.12K
Relative Volume:
0.59
時価総額:
$650.49M
収益:
$202.09M
当期純損益:
$-61.69M
株価収益率:
-9.6852
EPS:
-1.08
ネットキャッシュフロー:
$-35.64M
1週間 パフォーマンス:
+2.25%
1か月 パフォーマンス:
-19.72%
6か月 パフォーマンス:
-34.79%
1年 パフォーマンス:
-10.75%
1日の値動き範囲:
Value
$10.36
$10.73
1週間の範囲:
Value
$9.82
$10.97
52週間の値動き範囲:
Value
$8.67
$17.82

Evolus Inc Stock (EOLS) Company Profile

Name
名前
Evolus Inc
Name
セクター
Healthcare (1156)
Name
電話
(949) 284-4555
Name
住所
520 NEWPORT CENTER DRIVE, NEWPORT BEACH
Name
職員
332
Name
次回の収益日
2025-03-04
Name
最新のSEC提出書
Name
EOLS's Discussions on Twitter

EOLS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
EOLS
Evolus Inc
10.46 650.49M 202.09M -61.69M -35.64M -1.08
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
149.99 66.56B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.33 45.76B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.45 45.66B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
14.00 16.04B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
292.82 12.79B 2.76B 1.11B 898.10M 22.77

Evolus Inc Stock (EOLS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-17 開始されました BTIG Research Buy
2024-01-29 アップグレード Barclays Equal Weight → Overweight
2022-06-23 開始されました Needham Buy
2022-05-12 アップグレード Barclays Underweight → Equal Weight
2022-01-20 アップグレード Truist Hold → Buy
2021-05-06 アップグレード Mizuho Neutral → Buy
2021-04-08 繰り返されました H.C. Wainwright Buy
2021-02-24 ダウングレード Truist Buy → Hold
2020-07-07 ダウングレード Mizuho Buy → Neutral
2020-02-06 再開されました Mizuho Buy
2019-11-26 開始されました SVB Leerink Outperform
2019-09-05 再開されました Mizuho Buy
2019-06-28 開始されました Wells Fargo Market Perform
2019-06-11 開始されました Barclays Underweight
2019-03-20 開始されました SunTrust Buy
2019-02-14 開始されました H.C. Wainwright Buy
2019-01-29 開始されました Stifel Buy
すべてを表示

Evolus Inc (EOLS) 最新ニュース

pulisher
Apr 18, 2025

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | EOLS Stock News - GuruFocus

Apr 18, 2025
pulisher
Apr 18, 2025

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Apr 18, 2025
pulisher
Apr 18, 2025

Evolus Strengthens Talent Strategy: 30,579 RSUs Granted to Key New Hires with 2025 Vesting - Stock Titan

Apr 18, 2025
pulisher
Apr 18, 2025

Midday Stock Roundup: US Markets Closed for Good Friday - Orange County Business Journal

Apr 18, 2025
pulisher
Apr 18, 2025

Evolus announces commercial launch of Evolysse - MSN

Apr 18, 2025
pulisher
Apr 17, 2025

BTIG Initiates Coverage of Evolus (EOLS) with Buy Recommendation - Nasdaq

Apr 17, 2025
pulisher
Apr 17, 2025

BTIG Initiates Evolus at Buy With $21 Price Target - marketscreener.com

Apr 17, 2025
pulisher
Apr 17, 2025

Evolus initiated with a Buy at BTIG - TipRanks

Apr 17, 2025
pulisher
Apr 17, 2025

BTIG Initiates Coverage on Evolus (EOLS) with Optimistic Outlook | EOLS Stock News - GuruFocus

Apr 17, 2025
pulisher
Apr 16, 2025

Evolus Launches "Drop The F Word" To Redefine Aesthetic Injectables With Evolysse - Nasdaq

Apr 16, 2025
pulisher
Apr 16, 2025

Evolus Announces Commercial Launch of Evolysse™ | EOLS Stock New - GuruFocus

Apr 16, 2025
pulisher
Apr 16, 2025

Evolus Announces Commercial Launch of Evolysse™ - Yahoo Finance

Apr 16, 2025
pulisher
Apr 16, 2025

Evolus Launches “Drop the F Word” Campaign in Advance of the Com - GuruFocus

Apr 16, 2025
pulisher
Apr 15, 2025

Game-Changing Cold-X Technology: Evolus Revolutionizes Injectable Aesthetics with Natural Results - Stock Titan

Apr 15, 2025
pulisher
Apr 10, 2025

H.C. Wainwright maintains Buy on Evolus stock with $27 target - Investing.com

Apr 10, 2025
pulisher
Apr 10, 2025

H.C. Wainwright maintains Buy on Evolus stock with $27 target By Investing.com - Investing.com Canada

Apr 10, 2025
pulisher
Apr 09, 2025

Evolus stock hits 52-week low at $9.22 amid market challenges - Investing.com Canada

Apr 09, 2025
pulisher
Apr 09, 2025

Evolus stock hits 52-week low at $9.22 amid market challenges By Investing.com - Investing.com South Africa

Apr 09, 2025
pulisher
Apr 09, 2025

Midday Stock Roundup: Evolus, ICU Medical down - Orange County Business Journal

Apr 09, 2025
pulisher
Apr 09, 2025

Breaking Down Evolus: 8 Analysts Share Their Views - Benzinga

Apr 09, 2025
pulisher
Apr 09, 2025

Investors Give Evolus, Inc. (NASDAQ:EOLS) Shares A 31% Hiding - simplywall.st

Apr 09, 2025
pulisher
Apr 08, 2025

Evolus at Needham Conference: Strategic Launch of Evolisse By Investing.com - Investing.com Canada

Apr 08, 2025
pulisher
Apr 08, 2025

Evolus at Needham Conference: Strategic Launch of Evolisse - Investing.com

Apr 08, 2025
pulisher
Apr 07, 2025

Sandra Beaver: Evolus on Track to Hit $700M Revenue - Orange County Business Journal

Apr 07, 2025
pulisher
Apr 06, 2025

Recent 11% pullback isn't enough to hurt long-term Evolus (NASDAQ:EOLS) shareholders, they're still up 170% over 5 years - simplywall.st

Apr 06, 2025
pulisher
Apr 02, 2025

Evolus, Inc.: Navigating Financial Challenges Amidst Ongoing Losses and Market Uncertainty - MSN

Apr 02, 2025
pulisher
Mar 29, 2025

Evolus CEO David Moatazedi sells $77,512 in stock By Investing.com - Investing.com India

Mar 29, 2025
pulisher
Mar 28, 2025

Evolus CEO David Moatazedi sells $77,512 in stock - Investing.com Australia

Mar 28, 2025
pulisher
Mar 25, 2025

Evolus to Participate in The Needham 24th Annual Virtual Healthcare Conference - BioSpace

Mar 25, 2025
pulisher
Mar 25, 2025

Evolus Inc (EOLS) Shares Down 4.54% on Mar 25 - GuruFocus

Mar 25, 2025
pulisher
Mar 25, 2025

Evolus Leadership Reveals Growth Strategy at Major Healthcare Conference - Stock Titan

Mar 25, 2025
pulisher
Mar 23, 2025

Investing in Evolus (NASDAQ:EOLS) five years ago would have delivered you a 216% gain - Yahoo Home

Mar 23, 2025
pulisher
Mar 21, 2025

Evolus reports inducement grants under Nasdaq listing rule 5635(C)(4) -March 21, 2025 at 04:17 pm EDT - MarketScreener

Mar 21, 2025
pulisher
Mar 21, 2025

Evolus director David Moatazedi sells $1.37 million in stock By Investing.com - Investing.com Australia

Mar 21, 2025
pulisher
Mar 21, 2025

Evolus Growth Continues: 14 New Employees Join as Company Strengthens Talent Pool - Stock Titan

Mar 21, 2025
pulisher
Mar 21, 2025

Evolus to Participate in Canaccord Genuity’s 43rd Annual Growth Conference - Business Wire

Mar 21, 2025
pulisher
Mar 20, 2025

Evolus executive Avelar Rui sells $369,867 in stock By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

Evolus CFO Sandra Beaver sells $119,242 in company stock By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

Evolus chief marketing officer sells $60,124 in common stock By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

Evolus CFO Sandra Beaver sells $119,242 in company stock - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

Evolus director David Moatazedi sells $1.37 million in stock - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

Evolus chief marketing officer sells $60,124 in common stock - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

When the Price of (EOLS) Talks, People Listen - news.stocktradersdaily.com

Mar 20, 2025
pulisher
Mar 16, 2025

Trade Alert: Independent Director Of Evolus Karah Parschauer Has Sold Stock - Simply Wall St

Mar 16, 2025
pulisher
Mar 15, 2025

Evolus director Parschauer sells $167,465 in common stock By Investing.com - Investing.com India

Mar 15, 2025
pulisher
Mar 15, 2025

Demonstrates Effects Lasting 26 Weeks in Phase II Data Presented at 2023 ASDS Annual Meeting - Business Wire

Mar 15, 2025

Evolus Inc (EOLS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$8.89
price up icon 4.83%
$27.11
price up icon 0.41%
$99.57
price down icon 1.04%
$7.69
price up icon 1.59%
$101.74
price up icon 1.05%
$292.82
price up icon 3.01%
大文字化:     |  ボリューム (24 時間):